IVDiagnostics, Inc.

IVDiagnostics platform enables physicians to perform real-time monitoring of circulating tumor cells (CTCs) without taking blood.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Valparaiso, IN, USA
  • Currency USD
  • Founded October 2010
  • Employees 7
  • Website ivdiagnostics.com

Company Summary

IVDiagnostics is focused on non-toxic, affordable cancer assays, molecular diagnostics, and minimally invasive approaches to diagnosing patients and determining the effectiveness or ineffectiveness of therapy. The IVDx system is novel platform for monitoring CTCs with less patient anxiety, ease of use, less costly with high sensitivity.

Team

  • John D. Feczko, MD, PhD
    Chief Science Officer

    Practicing pathologist and cyto-pathologist. President, Medical Staff at Porter Health System, part of Community Health System. Member of Pathology Consultants Group.

  • Frank Szczepanski
    President and CEO

    Seasoned professional with nine startups in 20 years. Four exits totaling $10 billion in valuation. Responsible for generating $1 billion in sales thus far. Expertise in complex systems integration.

  • Wei He, PhD
    Chief Technology Officer

    PhD in Analytical Chemistry - Purdue University. Selected by Business Week as Top Six brightest sacademic stars and young entrepreneurs in America. Published in PNAS, International Journal of Cancer, Nano Research and American Biotechnology Laboratory.

  • Frank Szczepanski

Advisors

  • Baker Daniels; Stephen Kaplitt; Loeb & Loeb
    Lawyer
    Unconfirmed
    Darlene Kittredge, CPA
    Accountant
    Unconfirmed

Previous Investors

  • St. Louis Arch Angels; NJ Angels; TSC Ventures
    Unconfirmed
    Skandalaris Foundation; Hatchery Fund
    Unconfirmed
    40 Private Investors
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free